Efficacy of Enhanced Recovery After Surgery Pathway for Total Mastectomy
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 发起方
- 入组人数
- 386
- 主要终点
- perioperative opioid consumption
研究概览
简要总结
Retrospective analysis of pre and post-Enhanced Recovery after Surgery for Total mastectomy pathway implementation.
详细描述
Retrospective analysis of pre- and post-Enhanced Recovery after surgery for total mastectomy pathway implementation in patients at Mount Zion Hospital. We examined perioperative opioid consumption, pain scores, post-operative nausea and vomiting, benzodiazepine use, length of stay for the time period before and after implementation of an Enhanced Recovery after Surgery pathway for Total mastectomy. Pathway features included preoperative acetaminophen and gabapentin, minimizing opioids, postoperative NSAIDs, Pecs blocks, and aggressive postoperative nausea and vomiting prophylaxis.
研究设计
- 研究类型
- Observational
- 观察模型
- Cohort
- 时间视角
- Retrospective
入排标准
- 年龄范围
- 18 Years 至 —（Adult, Older Adult）
- 性别
- Female
- 接受健康志愿者
- 否
入选标准
- •female patients at least 18 years old undergoing total skin sparing mastectomy at University of California San Francisco Mount Zion hospital
排除标准
- •patients undergoing concurrent bilateral salpingo-oophorectomy, flap reconstruction
结局指标
主要结局
perioperative opioid consumption
时间窗: through study completion (average of 1 year)
perioperative opioid consumption
次要结局
- postoperative benzodiazepine use(through study completion (average of 1 year))
- Post-operative nausea and vomiting (PONV)(through study completion (average of 1 year))
- Length of stay (LOS)(through study completion (average of 1 year))
- Pain score(through study completion (average of 1 year))
- Surgery duration(through study completion (average of 1 year))
研究者
Monica Harbell
Assistant Professor
University of California, San Francisco